Contrast induced nephropathy definition
Contrast Induced Nephropathy Microchapters |
Differentiating Contrast induced nephropathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Contrast induced nephropathy definition On the Web |
American Roentgen Ray Society Images of Contrast induced nephropathy definition |
Directions to Hospitals Treating Contrast induced nephropathy |
Risk calculators and risk factors for Contrast induced nephropathy definition |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Definition
There are three necessary components for the definition of CIN:[1]
- Elevated serum creatinine compared to the baseline values.
- Temporal relationship between the rise in serum creatinine and exposure to a contrast agent.
- Exclusion of alternative explanations for renal impairment.
Contrast-induced nephropathy is defined as either a greater than 25% increase of serum creatinine or an absolute increase in serum creatinine of 0.5 mg/dL that occur 48–72 hours following the exposure to CM.[1][2] According to a study that aimed to describe the course of creatinine rise and its determinants after exposure to contrast media, the first 24 hours post-exposure appear to be crucial in the development of CIN.[1][3] The same study showed that patients with less than 0.5 mg/dl rise in serum creatinine within the first 24 h were unlikely to have any clinically meaningful form of CIN.
References
- ↑ 1.0 1.1 1.2 Mehran R, Nikolsky E (2006). "Contrast-induced nephropathy: definition, epidemiology, and patients at risk". Kidney Int Suppl (100): S11–5. doi:10.1038/sj.ki.5000368. PMID 16612394.
- ↑ Barrett BJ, Parfrey PS (2006). "Clinical practice. Preventing nephropathy induced by contrast medium". N. Engl. J. Med. 354 (4): 379–86. doi:10.1056/NEJMcp050801. PMID 16436769.
- ↑ Guitterez NV, Diaz A, Timmis GC, O'Neill WW, Stevens MA, Sandberg KR; et al. (2002). "Determinants of serum creatinine trajectory in acute contrast nephropathy". J Interv Cardiol. 15 (5): 349–54. PMID 12440177.